The Biden regime is continuing its war on red states over their refusal to buckle under his demands to re-impose pointless, needless COVID-19 restrictions, this time by 'taking over' distribution of the highly effective medication ivermectin, and then refusing to send it to them.
One of the states Biden's regime really resents is Florida, where liberty-minded GOP Gov. Ron DeSantis has pushed back hard on the White House and its health hacks like Dr. Tony Fauci and CDC Director Rochelle Walensky, and of course, it was one of the first red states denied ivermectin.
But because he's one of the best governors in the country, DeSantis has already figured out a workaround, which will also, most likely, anger the regime.
"Just last week on September 9th, President Joe Biden said that his administration would be increasing shipments of monoclonal antibodies in September by 50 percent, and yet on September 13th, HHS announced that it was seizing control of the monoclonal antibody supply and that it would control distribution," DeSantis said during a press conference last week.
"Then on September 14th, the announcement was more than 50 percent of the monoclonal antibodies that had been used in Florida were going to be reduced," he added.
The governor said that Biden's "dramatic reduction' is "doubly problematic" because "what Shane Strum and folks in Tampa General and these other hospital systems that have been doing this, they’re not getting it from the state.”
"What the HHS and the Biden administration is now doing is they’re saying that all of the reduced amount will go to the state, and we’re responsible not only for sourcing our sites, which we’re happy to do, but any infusion center," the governor continued to explain. "Any provider, any hospital will have to come through the state, and to just spring this on us starting next week, we’re going to have to do that. There’s going to be a huge disruption and patients are going to suffer as a result of this," DeSantis said, pointing out that the regime is actually not harming him, it is harming Floridians -- over a political disagreement.But again, DeSantis has found a workaround, as The Post Millennial reports:DeSantis said he received a call Wednesday from GlaxoSmithKline executives on possibly ordering their monoclonal antibody to avoid Biden’s restriction on the life-saving treatment.A DeSantis aide told Philip Webmann of Real Clear News that the Department of Health and Human Services (HHS) has not yet bothered to tell Florida officials why the ivermectin cut was implemented.
"They had a vague statement about 'equity,' but sorry, that doesn't cut it. No explanation of how the allocation was determined. No explanation of why it's only Florida and a few other red states being restricted. No warning," the aide told the outlet. HHS announced Sept. 13 that the agency would begin taking over control and distribution of the treatment, which told political opponents like DeSantis what was coming.Later the same day, the Florida Department of Health told HHS it needed 36,000 doses per week to supply 25 state-run sites, but the federal health agency did not say that a shortage was forthcoming, "just that they were monitoring more closely," the aide said.
But then the following day, Sept. 14, HHS sent an email to the state health agency that their allocation of treatments for the week would be "3,100 doses of BAM/ETE and 27,850 doses of REGN-COV."
"Contradicting recent and previous guidance from HHS, this was the first and only indication that Florida would receive a decreased supply and would be responsible for allocating among facilities," according to a timeline issued by the state. "I will fight like hell to overcome Biden’s cruel decision to drastically reduce life-saving monoclonal antibody treatments for Floridians. We've seen steep reductions in hospital admissions due to early treatment efforts. It’s wrong to penalize Florida for his partisan bitterness," DeSantis vowed.https://twitter.com/GovRonDeSantis/status/1438676026335408130The latest news about COVID-19 can be found at Pandemic.news.
